Synergistically overexpression of WT1 and STAT3 in tumor development, including Wilms’ tumor, increases the expression level of STAT3 target genes, including cyclin D1 and Bcl-xL, resulting in an advantage of cell proliferation. Here, BCL2L1 is linked to Wilms tumor.